This was in line with a positive correlation between sPD-L1 levels in the CSF of MS patients and increased AhR activity (Fig. 2p and Table 1), indicating that microbial metabolites may contribute to immune checkpoint signaling in the CNS of MS patients. This evidence concerns the gene SPDL1 and myeloid sarcoma.